[1]
|
World Health Organization (2020) Q&A on Coronaviruses (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses
|
[2]
|
Subhash Unhale, S., Bilal, Q., Sanap, S., Thakhre, S., Wadatkar, S., Bairagi, R., et al. (2020) A Review of Corona Virus (COVID-19). International Journal of Pharmaceutical and Life Sciences, 6, 109-115.
|
[3]
|
Wu, Y., Chen, C. and Chan, Y. (2020) The Outbreak of COVID-19: An Overview. Journal of the Chinese Medical Association, 83, 217-220. https://doi.org/10.1097/JCMA.0000000000000270
|
[4]
|
Poudel Adhikari, S., Meng, S., Wu, Y.-J., Mao, Y.-P., Ye, R.-X., Wang, Q.-Z., et al. (2020) Epidemiology, Causes, Clinical Manifestations and Diagnosis, Prevention and Control of Corona Virus (COVID-19) during the Early Outbreak Period: A Scoping Review. Infectious Disease of Poverty, 9, Article No. 29. https://doi.org/10.1186/s40249-020-00646-x
|
[5]
|
Hagerty, S.L. and Williams, L.M. (2020) The Impact of COVID-19 on Mental Health: the Interactive Roles of Brain Biotypes and Human Connection. Brain, Behavior & Immunity-Health, 5, Article ID: 100078. https://doi.org/10.1016/j.bbih.2020.100078
|
[6]
|
Zirui Tay, M., Poh, C.M., Rénia, L., MacAry, P.A. and Lisa Ng, F.P. (2020) The Trinity of COVID-19: Immunity, Inflammation and Intervention. Nature Reviews Immunology, 20, 363-374. https://doi.org/10.1038/s41577-020-0311-8
|
[7]
|
Belvis, R. (2020) Headaches during COVID-19. My Clinical Case and Review of the Literature. Headache, 60, 1422-1426. https://doi.org/10.1111/head.13841
|
[8]
|
Meng, X., Deng, Y., Dai, Z. and Meng, Z. (2020) COVID-19 and Anosmia: A Review Based on Up-to-Date Knowledge. American Journal of Otolaryngology, 42, Article ID: 102581. https://doi.org/10.1016/j.amjoto.2020.102581
|
[9]
|
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., et al. (2020) Neurologic Features in Severe SARS-COV-2 Infection. New England Journal of Medicine, 382, 2268-2270. https://doi.org/10.1056/NEJMc2008597
|
[10]
|
Paterson, R.W., Brown, R.L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., et al. (2020) The Emerging Spectrum of COVID-19 Neurology: Clinical, Radiological and Laboratory Findings. Brain, 143, 3104-3120. https://doi.org/10.1093/brain/awaa240
|
[11]
|
Fotuhi, M., Mian, A., Meysami, S. and Raji, C.A. (2020) Neurobiology of COVID-19. Journal of Alzheimer’s Disease, 76, 3-19. https://doi.org/10.3233/JAD-200581
|
[12]
|
Koralnik, I.J. and Tyler, K.L. (2020) COVID-19: A Global Threat to the Nervous system. Annals of Neurology, 88, 1-11. https://doi.org/10.1002/ana.25807
|
[13]
|
Sharma, S. and Ebadi, M. (2014) The Charnoly Body as a Universal Biomarker of Cell Injury. Biomarkers and Genomic Medicine, 6, 89-98. https://doi.org/10.1016/j.bgm.2014.03.004
|
[14]
|
Sharma, S. (2020) Re: How Does COVID-19 Infection Affect the Brain? https://www.researchgate.net/post/How_does_COVID-19_infection_affect_the_brain/5ea6e3902c97d8302b2e3cf9/citation/download
|
[15]
|
DosSantos, M.F., Devalle, S., Aran, V., Capra, D., Roque, N.R., Coelho-Aguiar, J.M., et al. (2020) Neuromechanisms of SARS-CoV-2. Frontiers in Neuroanatomy, 14, Article No. 37. https://doi.org/10.3389/fnana.2020.00037
|
[16]
|
Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.L., Abiona, O., et al. (2020) Cryo-EM Structure of 2019-nCoV Spike in the Perfusion Conformation. Science, 367, 1260-1263. https://doi.org/10.1126/science.abb2507
|
[17]
|
Elena, C., Carmine, V. and Annibale, A.P. (2020) COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children. Frontiers in Pediatrics, 8, Article No. 206. https://doi.org/10.3389/fped.2020.00206
|
[18]
|
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., et al. (2005) A Crucial Role of Angiotensin Converting Enzyme 2 (ACE2) in SARS Coronavirus-Induced Lung Injury. Nature Medicine, 11, 875-879. https://doi.org/10.1038/nm1267
|
[19]
|
Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S. and Griffith, B. (2020) COVID-19 Associated Acute Haemorrhagic Necrotizing Encephalopathy: CT and MRI Features. Radiology, 296, E119-E120. https://doi.org/10.1148/radiol.2020201187
|
[20]
|
South, A.M., Brady, T.M. and Flynn, J.T. (2020) ACE2 (Angiotensin Converting Enzyme 2), COVID-19 and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use during the Pandemic. Hypertension, 76, 16-22. https://doi.org/10.1161/HYPERTENSIONAHA.120.15291
|
[21]
|
Mackey, K., King, V.J., Gurley, S., Kiefer, M., Liederbauer, E., Vela, K., et al. (2020) Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Annals of Internal Medicine, 173, 195-203. https://doi.org/10.7326/m20-1515
|
[22]
|
Khera, R., Clark, C., Lu, Y., Guo, Y., Ren, S., Truax, B., et al. (2020) Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19. Journal of the American Heart Association, e018086.
|
[23]
|
Al-Obaidi, M.M.J., Bahadoran, A., Wang, S.M., Manikam, R., Raju, C.S., et al. (2018) Disruption of the Blood Brain Barrier Is Vital Property of Neurotropic Viral Infection of the Central Nervous System. Acta Virologica, 62, 16-27. https://doi.org/10.4149/av_2018_102
|
[24]
|
Rachel, B., Brit, L. and Michael, G. (2020) Neurological Complications of COVID-19. American Journal of Emergency Medicine, 38, 1549.e3-1549.e7. https://doi.org/10.1016/j.ajem.2020.05.024
|
[25]
|
Wu, Y., Xu, X., Yang, L., Liu, C. and Yang, C. (2020) Nervous System Damage after COVID-19 Infection: Presence or Absence. Brain, Behavior, and Immunity, 87, 55. https://doi.org/10.1016/j.bbi.2020.04.043
|
[26]
|
Wu, Y., Xu, X., Chen, Z., Chen, Z., Duan, J., Hashimoto, K., et al. (2020) Nervous System Involvement after Infection with COVID-19 and Other Coronaviruses. Brain, Behavior, and Immunity, 87, 18-22. https://doi.org/10.1016/j.bbi.2020.03.031
|
[27]
|
Pleasure, S.J., Green, A.J. and Andrew Josephson, S. (2020) The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection. Neurologist Move to the Frontlines. JAMA Neurology, 77, 679-680. https://doi.org/10.1001/jamaneurol.2020.1065
|
[28]
|
Toscano, G., Palmerini, F., Ravaglia, S., Ruiz, L., Invernizzi, P., Giovanna Cuzzoni, M., et al. (2020) Guillain Barre Syndrome Associated with SARS-CoV-2. New England Journal of Medicine, 382, 2574-2576. https://doi.org/10.1056/NEJMc2009191
|
[29]
|
Gutiérrez-Ortiz, C., Méndez-Guerrero, A., Rodrigo-Rey, S., San Pedro-Murillo, E., Bermejo-Guerrero, L., Gordo-Maňas, R., et al. (2020) Miller Fisher Syndrome and Polyneuritis Cranialis in COVID-19. Neurology, 95, e601-e605. https://doi.org/10.1212/wnl.0000000000009619
|
[30]
|
Nobuhiro, Y. (2007) Ganglioside Mimicry and Peripheral Nerve Disease. Muscle & Nerve, 35, 691-711. https://doi.org/10.1002/mus.20762
|
[31]
|
Suzuki, M., Saito, K., Min, W.-P., Vladau, C., Toida, K., Itoh, H., et al. (2007). Identification of Viruses in Patients with Post Viral Olfactory Dysfunction. Laryngoscope, 117, 272-277. https://doi.org/10.1097/01.mlg.0000249922.37381.1e
|
[32]
|
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., et al. (2020). Self-Reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross Sectional study. Clinical Infectious Diseases, 71, 889-890. https://doi.org/10.1093/cid/ciaa330
|
[33]
|
Gilani, S., Roditi, R. and Naraghi, M. (2020) COVID-19 and Anosmia in Tehran, Iran. Medical Hypotheses, 141, Article ID: 109757. https://doi.org/10.1016/j.mehy.2020.109757
|
[34]
|
Mannan Baig, A., Khaleeq, A., Ali, U. and Syeda, H. (2020) Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. Chemical Neuroscience, 11, 995-998. https://doi.org/10.1021/acschemneuro.0c00122
|
[35]
|
Lechien, J.R., Chiesa-Estomba, C.M., De Siati, D.R., Horoi, M., Le Bon, S.D., Rodriguez, A., et al. (2020) Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild to Moderate forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. European Archives of Oto-Rhino-Laryngology, 277, 2251-2261. https://doi.org/10.1007/s00405-020-05965-1
|
[36]
|
Vaira, L.A., Salzano, G., Deiana, G. and De Riu, G. (2020) Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope, 130, 1787. https://doi.org/10.1002/lary.28692
|